Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous peripheral blood CD34+ cell transplantation for chronic critical limb ischemia (TRIASO0704)
jRCT2090220022Completed
- Sponsor
- Atsuhiko Kawamoto
- Start
- Sep 2008
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of autologous peripheral blood CD34+ cells in chronic limb-threatening ischemia (CLTI) and arteriosclerosis obliterans, sponsored by Atsuhiko Kawamoto. Started Sep 2008; status: completed.
02
Drugs
autologous peripheral blood CD34+ cells
03
Conditions
chronic limb-threatening ischemia (CLTI)arteriosclerosis obliterans
Beyond the preview
Go deeper on jRCT2090220022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2090220022.